Avistone Pharmaceuticals Biotechnology

Beijing, China · Founded 2018 · In IPO Registration

Developer of innovative drugs for tumor treatment. Avistone Pharmaceuticals Biotechnology is based in Beijing, China and was founded in 2018. Its last reported valuation was $628 million in Mar 2025. It has raised $372 million.

Last reported valuation
$628.3M
Oct 2026
Priced at
—
Total raised
$372.0M
Last round
—

Who backs Avistone Pharmaceuticals Biotechnology?

11 investors
InvestorType
IDG CapitalVenture capital
Bain CapitalPE / buyout
Cathay CapitalPE / buyout
CMG SDIC FundVenture capital
Vivo CapitalVenture capital
Primavera Capital GroupGrowth equity
Bain Capital Life SciencesVenture capital
Beishang Capital Management (Beijing)Other
CBC Group (Singapore)—
Yanchuang Capital—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Avistone Pharmaceuticals Biotechnology investors

11 investors are on record for Avistone Pharmaceuticals Biotechnology, including IDG Capital, Bain Capital, Cathay Capital and CMG SDIC Fund. By type, the record holds 4 venture capital firms, 2 private equity firms and 1 growth equity firm.

Free account
More of Avistone Pharmaceuticals Biotechnology with a free account
  • ·The complete investor list: 11 names
  • ·Watch Avistone Pharmaceuticals Biotechnology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Avistone Pharmaceuticals Biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View